Acrisure and the Medical Protection Society (MPS) have announced senior leadership appointments designed to sustain growth and ensure operational continuity across their respective sectors.The appointments come after a period of activity for the company as it continues to build a unified presence following the rebrand of several UK broker acquisitions.
Acrisure has added three executives to its UK retail leadership team, while MPS confirmed the return of Dr. Pallavi Bradshaw as its next medical director following Dr. Rob Hendry’s promotion to chief member officer. Acrisure’s new leadership additions include David Cramp as chief revenue officer, Rob White as chief risk and compliance officer and Rowanne Dicker as head of UK Retail Markets and Placement. All three will report to Acrisure UK CEO Mark McIlquham.
Cramp brings more than 20 years of market experience in risk and client relations. In his new role, he will work with teams in the United States and across Acrisure’s network to manage revenue and business opportunities. White, who has held compliance and risk roles in global insurers, brokers, and financial services firms, will focus on governance and compliance objectives. Dicker will oversee market access and placement, applying her experience in insurer partnerships and broker development.
“David, Rob and Rowanne each bring valuable expertise and leadership to Acrisure,” said McIlquham. “Their appointments further strengthen our senior team as we continue to drive the business forward, supporting our people, partners and clients for the long term.”
In the healthcare sector, MPS named Bradshaw as medical director, a role that involves engaging with healthcare leaders and representing the interests of more than 300,000 professionals and organisations globally.
Bradshaw, currently medical director at AXA Health, has over two decades of experience in healthcare, including 14 years in senior roles at MPS supporting doctors and advising on professional conduct. She began her career in clinical medicine after graduating from St Catharine’s College, Cambridge, and completing her ophthalmology training at Addenbrooke’s Hospital.
“I am absolutely delighted to be returning to MPS, an organisation close to my heart,” she said. “I left clinical practice with the ambition to support my peers and colleagues. I am honoured to take on this role to represent members and their interests across the world in an ever evolving and challenging healthcare environment.”
Hendry said Bradshaw’s appointment brings extensive medicolegal knowledge and experience in health insurance, consistent with MPS’s focus on keeping members central to its operations. She is expected to assume her new role in early 2026.
How do you see these leadership transitions affecting Acrisure and MPS in their respective industries? Share your thoughts in the comments.
